Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

11.93
-0.0100-0.08%
Post-market: 11.93-0.0070-0.06%17:20 EDT
Volume:4.45M
Turnover:53.12M
Market Cap:8.15B
PE:-17.24
High:12.03
Open:11.90
Low:11.85
Close:11.94
52wk High:13.06
52wk Low:8.73
Shares:682.88M
Float Shares:414.56M
Volume Ratio:0.99
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6921
EPS(LYR):-0.2371
ROE:-18.15%
ROA:-12.59%
PB:1.87
PE(LYR):-50.32

Loading ...

Company Profile

Company Name:
Roivant Sciences Ltd.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
750
Office Location:
11-12 St. James's Square,Suite 1,3rd Floor,London,Greater London,United Kingdom
Zip Code:
SW1Y 4LB
Phone:
- -
Fax:
- -
Introduction:
Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.

Directors

Name
Position
Matthew Gline
Director & Chief Executive Officer
Ilan Oren
Director & Chair
Mayukh Sukhatme
President and Chief Investment Officer and Director
Daniel Gold
Director
James C. Momtazee
Director
Keith Manchester
Director
Meghan FitzGerald
Director
Melissa Epperly
Director

Shareholders

Name
Position
Matthew Gline
Director & Chief Executive Officer
Richard Pulik
Chief Financial Officer
Eric Venker
President and Immunovant CEO
Frank Torti
President and Vant Chair
Jennifer Humes
Chief Accounting Officer
Mayukh Sukhatme
President and Chief Investment Officer and Director